Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(TSX: SVA )

0.1750 -0.0100 (-5.41%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SVA

< Previous 1 2 Next >
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Issues Statement Regarding Privy Council Judgment
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Announces Key New Executive Appointments
Experienced leadership team positions company to advance Cell Pouch™ bio-hybrid organ programs. 
Via TheNewswire.com
Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
SINOVAC Reports Unaudited First Half of 2024 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Provides Positive Clinical and Platform Portfolio Update
With recent positive findings in post-surgical hypothyroidism large animal study, Sernova anticipates filing an Investigational New Drug (IND) application in 2024 
Via TheNewswire.com
Sinovac Amends Shareholder Rights Plan
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Announces Change of Legal Representative of Sinovac Beijing
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited First Half of 2023 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
Via Investor Brand Network
Sinovac Amends Shareholder Rights Plan
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited First Half of 2022 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.  
Via Benzinga
SINOVAC Varicella Vaccine Prequalified by WHO
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC to Showcase Products at CPHI Frankfurt
From Sinovac Biotech Ltd.
Via Business Wire
SVA DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
SINOVAC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sinovac Biotech Ltd. (SVA) Investors of Class Action Deadline Against 1Globe Capital LLC and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Deadline in Lawsuit on October 17, 2022
San Diego, CA -- (SBWIRE) -- 10/10/2022 -- The Shareholders Foundation announced that a deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Sinovac Biotech Ltd.... 
Via SBWire
SVA FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA
From The Rosen Law Firm, P.A.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS